ArticleNature communications2026
A Rras2-BMPR2 feedback loop sustains osteogenesis and represents a therapeutic target for osteoporosis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ras-related protein 2 (Rras2) mutations are linked to Noonan syndrome, a disorder characterized by skeletal dysplasia and growth deficits. However, the role of Rras2 in bone homeostasis remains poorly defined, hindering the development of clinical interventions. Here, we show that Rras2 deficiency in mice leads to osteopenia, reduced bone strength, and impaired osteogenesis, recapitulating the clinical features of human patients. Mechanistically, Rras2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells and supports bone regeneration. At the molecular level, Rras2 sustains BMP signaling by blocking Smurf1-dependent ubiquitination and degradation of BMPR2; in turn, BMP signaling enhances Rras2 transcription. Osteoporotic mice exhibit marked reduction in Rras2 expression in bone, and adeno-associated virus 9 (AAV9)-mediated restoration of Rras2 rescues bone loss. Our findings identify a Rras2-BMPR2 positive feedback loop that is critical for bone homeostasis and provide a therapeutic avenue for osteoporosis and Noonan syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.